Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Radiotherapy in Hepatocellular Carcinomas After Hepatectomy With Narrow Margin (<1 cm) and / or Microvascular Invasion

NCT02678806 is registered in ClinicalTrials.gov with Guangxi Medical University as lead sponsor.

NCT NCT02678806
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02678806 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Radiotherapy in Hepatocellular Carcinomas After Hepatectomy With Narrow Margin (<1 cm) and / or Microvascular Invasion
Lead sponsor
Guangxi Medical University
Phase
Not applicable
Overall status
Unknown status
Start date
November 1, 2017
Completion date
November 1, 2022
Enrollment
620 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hepatocellular carcinoma